Loneliness Group Intervention

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05619718
Collaborator
(none)
50
2
15

Study Details

Study Description

Brief Summary

The goal of this pilot study is to determine the feasibility and acceptability of a group loneliness intervention in geriatric psychiatry inpatients. This type of group loneliness intervention is based on functional analytic psychotherapy and is called Awareness, Courage, and Love Groups.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Awareness, Courage, and Love Groups
  • Other: Mutual Help Meetings
N/A

Detailed Description

The objective of our clinical trial is to adapt, implement, and evaluate a type of loneliness group intervention called Awareness, Courage, and Love Groups for older adults in a psychiatric unit. The following research questions will be answered: (a) Are such loneliness groups with geriatric psychiatry inpatients feasible and acceptable? (b) Do such loneliness groups demonstrate preliminary efficacy?

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Loneliness Group Intervention for Geriatric Psychiatry Inpatients
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment

Treatment group will receive Awareness, Courage, and Love Groups for loneliness.

Behavioral: Awareness, Courage, and Love Groups
Groups based on the Awareness, Courage, and Love framework from functional analytic psychotherapy

Active Comparator: Control

Control group will receive treatment as usual in the form of Mutual Help Meetings.

Other: Mutual Help Meetings
Groups based on treatment as usual where patients gather to discuss how they can help others on the ward, and make requests for how others can help them.

Outcome Measures

Primary Outcome Measures

  1. Inclusion of Other in the Self Scale (IOS) [Up to 2 months]

    Brief single-item pictorial measure of social closeness. The minimum value is 1, the maximum value is 7, and higher scores indicate a better outcome.

  2. UCLA Loneliness Scale (ULS-6) [Up to 2 months]

    Brief measure of loneliness. The minimum value is 6, the maximum value is 24, and higher scores indicate a worse outcome.

  3. Relational Health Indices (RHI) [Up to 2 months]

    Brief measure of group relational health. The minimum value is 8, the maximum value is 40, and higher scores indicate a better outcome.

  4. Quantitative Program Satisfaction [Up to 2 months]

    Brief measure of program satisfaction. The minimum value is 0, the maximum value is 16, and higher scores indicate a better outcome.

Secondary Outcome Measures

  1. Cantril Self-Anchoring Striving Scale [Up to 2 months]

    1 item pictorial scale of subjective wellbeing from 0 (minimum) to 10 (maximum). A higher score indicates a better outcome.

  2. Sacred Moment Qualities (SMQ) [Up to 2 months]

    Brief measure of perceived sacred qualities, adapted from Pargament et al. (2014). The minimum value is 11, the maximum value is 55, and higher scores indicate a better outcome.

Other Outcome Measures

  1. Satisfaction Questionnaire [Up to 2 months]

    Brief open-ended questions about program satisfaction. Responses are qualitative.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admission to geriatric psychiatry inpatient unit

  • Montreal Cognitive Assessment (MoCA) score of 10 or above

Exclusion Criteria:
  • Individuals who are disoriented to person, delirious, unable to tolerate or participate meaningfully in the group, or otherwise unable to provide consent to research

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

  • Principal Investigator: Michele Doering, MD, St. Joseph's Health Care London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT05619718
Other Study ID Numbers:
  • 12528
First Posted:
Nov 17, 2022
Last Update Posted:
Jan 17, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lawson Health Research Institute

Study Results

No Results Posted as of Jan 17, 2023